Heinz Schmitz

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Pearl Index study with levonorgestrel-releasing intravaginal rings: using pharmacokinetic results to investigate treatment compliance as a potential contributor for contraceptive failure.

Pearl Index study with levonorgestrel-releasing intravaginal rings: using pharmacokinetic results to investigate treatment compliance as a potential contributor for contraceptive failure.

Journal: Human reproduction (Oxford, England)

Published: April 22, 2020

Patients' and clinicians' perspectives on item importance, scoring, and clinically meaningful differences for the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS).

Patients' and clinicians' perspectives on item importance, scoring, and clinically meaningful differences for the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS).

Journal: Health and quality of life outcomes

Published: April 21, 2020

A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies.

A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies.

Journal: Therapeutic innovation & regulatory science

Published: June 18, 2019

A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies.

A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies.

Journal: Therapeutic innovation & regulatory science

Published: January 24, 2019

Absence of Drug-Drug Interaction of Anastrozole on Levonorgestrel Delivered Simultaneously by an Intravaginal Ring: Results of a Phase 2 Trial.

Absence of Drug-Drug Interaction of Anastrozole on Levonorgestrel Delivered Simultaneously by an Intravaginal Ring: Results of a Phase 2 Trial.

Journal: Journal of clinical pharmacology

Published: November 14, 2018

Efficacy, safety and tolerability of the CCR1 antagonist BAY 86-5047 for the treatment of endometriosis-associated pelvic pain: a randomized controlled trial.

Efficacy, safety and tolerability of the CCR1 antagonist BAY 86-5047 for the treatment of endometriosis-associated pelvic pain: a randomized controlled trial.

Journal: Acta obstetricia et gynecologica Scandinavica

Published: September 19, 2016

Model-Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis Symptoms.

Model-Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis Symptoms.

Journal: Journal of clinical pharmacology

Published: September 01, 2016

Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial.

Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial.

Journal: Human reproduction (Oxford, England)

Published: December 22, 2015

Characterization of anastrozole effects, delivered by an intravaginal ring in cynomolgus monkeys.

Characterization of anastrozole effects, delivered by an intravaginal ring in cynomolgus monkeys.

Journal: Human reproduction (Oxford, England)

Published: November 30, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026